Cost Effective Analysis

Management of Diabetes mellitus type 2 with hypertension is very complex process as it is very difficult to find which therapy gives better action in diabetic and hypertensive patients  The patients with Diabetes Mellitus and Hypertension were identified and they are enrolled based on inclusion and exclusion criteria. Data was collected through standard data documentation form. A prospective study was carried out and cost effective analysis of those drugs was done. The scores obtained are evaluated & analyzed using statistical tools and Microsoft Excel software This study has shown that oral hypoglycemic drugs which are cheap i.e.  Is 1.0 rs, per day, per week it costs 7rs, per fifteen days it costs 15 rs, per month it costs 30.5 rs and per year it costs 365 rs. for diabetes and  for hypertension  Beta blockers were low priced  10.17 rs per day ,per week  it costs 71.19rs, per fifteen days it costs 152.55rs,  per month it is 315.27 rs,  per  year   it is  3712 rs, categorized  medication and at the same time it gives better therapeutic action in terms of  treatment  outcomes. Over all study has shown that combination therapy will attribute to the better treatment outcomes. Use of generic drugs should be encouraged than prescribing brand drugs because of same therapeutic out come and it cause more economic burden to patient and more complications. There is a need of educating patients to motivate them in order to make them realize the risk involved if untreated.